Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
NEJM 354:1489-1496, Gould,D.B.,et al, 2006
ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006
Patients With Transient Ischemic Attack or Minor Stroke Should Be Admitted to Hospital: For
Stroke 37:1137-1138,1140, Hill,M.D. &Gladstone,D.J., 2006
Prevalence and Intensity of Pain After Stroke: A Population Based Study Focusing on Patients Perspectives
JNNP 77:590-595, Jnsson,A.-C.,et al, 2006
Clopidogrel and Aspiring versus Aspirin Alone for the Prevention of Atherothrombotic Events
NEJM 354:1706-1717,1744, Bhatt,D.L.,et al, 2006
Prospective Study of Symptomatic Atherothrombotic Intracranial Stenoses. The GESICA Study
Neurol 66:1187-1191, Mazighi,M.,et al, 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Stroke 37:1217-1220, Somerfield,J.,et al, 2006
Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke. A Systematic Review.
Stroke 37:1334-1339, Bandera,E.,et al, 2006
Does the Merci Retriever Work? For.
Stroke 37:1340-1341, Saver,J.L., 2006
Does the Merci Retriever Work? Against.
Stroke 37:1341-1342, Wechsler,L.R., 2006
Perceptual, Social, and Behavioral Factors Associated With Delays in Seeing Medical Care in Patients With Symptoms of Acute Stroke
Stroke 37:1248-1253, Mandelzweig,L.,et al, 2006
Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006
MR Diffusion-Weighted Imaging and Outcome Prediction After Ischemic Stroke
Neurol 66:1159-1163, Hand,P.J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia
AJNR 27:1037-1039, Mascalchi,M.,et al, 2006
Small Vessels, Big Problems
NEJM 354:1451-1453, Greenberg,S.M., 2006
Carotid Artery Dissection After Treadmill Running
Br J Sports Med 50:e10-311, Macdonald,D.J.M. &McKillop,E.C.A., 2006
Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006
Upside Down Reversal of Vision Due to an Isolated Acute Cerebellar Ischemic Infarction
J Neurol 253:953-954, Hern�ndez,A.H.,et al, 2006
ANCA-Associated Vasculitis (AAV) causing Bilateral Cerebral Infarction and Subsequent Intracerebral Hemorrhage without Renal and Respiratory Dysfunction
J Neurol Sci 240:99-101, Ito, Y.,et al, 2006
Post-operative aspergillosis
Clin Microbiol Infect 12:1060-1076, Pasqualotto, A.C. & Denning, D.W., 2006
Transient Hemiageusia in Cerebrovascular Lateral Pontine Lesions
JNNP 77:680-683, Landis, B.N.,et al, 2006
Taste Disorders in Acute Stroke
Stroke 36:1690-1694, Heckmann, J.G.,et al, 2005
Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005
Prognosis and Decision Making in Severe Stroke
JAMA 294:725-733, Holloway,R.G.,et al, 2005
Pure Monoparesis
Arch Neurol 62:1221-1224, Maeder-Ingvar,M.,et al, 2005
Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke
Arch Neurol 62:1217-1220, Maulaz,A.B.,et al, 2005
Posterior Cerebral Artery Infarction From Middle Cerebral Artery Infarction
Arch Neurol 62:938-941, Maulaz,A.B.,et al, 2005
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005
FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
Acute Intermittent Porphyria Presenting as a Diffuse Encephalopathy
Ann Neurol 67:581-584, Maramattom,B.V.,et al, 2005
Corpus Callosum Changes Following Shunting for Hydrocephalus: Case Report and Review of the Literature
Clin Neurology and Neurosurgery 107:351-354, Constantinescu,C.S.,et al, 2005
Fatal Toxic Leukoencephalopathy: Clinical, Radiological, and Necropsy Findings in Two Patients
JNNP 76:1014-1016, Ryan,A.,et al, 2005
Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005
Tourettes Syndrome and Deep Brain Stimulation
JNNP 76:992-995, Houeto,J.L.,et al, 2005
Prognositc Implications of Right-Sided Insular Damage, Cardiac Autonomic Derangement, and Arrhythmias After Acute Ischemic Stroke
Stroke 36:1710-1715, Colivicchi,F.,et al, 2005
Specific DWI Lesion Patterns Predict Prognosis After Acute Ischaemic Stroke Within the MCA Territory
JNNP 76:1222-1228,1187, Bang,O.Y.,et al, 2005
Silent Ischemia in Minor Stroke and TIA Patients Identified on MR Imaging
Neurol 65:513-517, Coutts,S.B.,et al, 2005
Phaeochromocytoma
Lancet 366:665-675, Lenders,J.W.M.,et al, 2005
Chagas Disease Is an Independent Risk Factor for Stroke
Stroke 36:2015-2017, Oliveira-Filho,J.,et al, 2005
REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005
Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005
Association of the Metabolic Syndrome with Intracranial Atherosclerotic Stroke
Neurol 65:296-298,188, Bang,O.Y.,et al, 2005
Lipid-Lowering Agent Use at Ischemic Stroke Onset is Associated with Decreased Mortality
Neurol 65:253-258, Elkind,M.S.V.,et al, 2005
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005
Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohns Disease
NEJM 353:362-368, Van Assche,G.,et al, 2005
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005
Effect of Timing and Method of Enteral Tube Feeding For Dysphagic Stroke Patients (FOOD): a Multicentre Randomised Controlled Trial
Lancet 365:764-772, 729, The FOOD Trial Collaboration, 2005